Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Guizhou Bailing Group Pharmaceutical Co Ltd cash flow reinvestment rate. Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting CN¥3.59 Million (capex CN¥3.59 Million ) from operating cash flow of CN¥294.76 Million. Explore how well can Guizhou Bailing Group Pharmaceutical Co service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guizhou Bailing Group Pharmaceutical Co Ltd (2009–2025)
Cash flow reinvestment rate of Guizhou Bailing Group Pharmaceutical Co Ltd from 2009 to 2025. Historical reinvestment intensity for Guizhou Bailing Group Pharmaceutical Co Ltd across 15 annual periods. Explore how much does Guizhou Bailing Group Pharmaceutical Co reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2009–2025)
Guizhou Bailing Group Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2009 to 2025. Year-by-year capital reinvestment analysis for Guizhou Bailing Group Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002424 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥131.71 Million | CN¥748.72 Million | CN¥125.24 Million | ▼ -99.1% |
| 2024 | 20.46x | CN¥184.60 Million | CN¥9.02 Million | CN¥42.02 Million | ▲ +1892.6% |
| 2023 | 1.03x | CN¥129.16 Million | CN¥125.77 Million | CN¥104.12 Million | ▲ +245.6% |
| 2022 | 0.30x | CN¥149.20 Million | CN¥502.15 Million | CN¥68.45 Million | ▼ -83.6% |
| 2021 | 1.81x | CN¥587.80 Million | CN¥324.92 Million | CN¥425.73 Million | ▲ +318.8% |
| 2020 | 0.43x | CN¥100.12 Million | CN¥231.78 Million | CN¥90.02 Million | ▼ -65.6% |
| 2019 | 1.26x | CN¥587.02 Million | CN¥467.41 Million | CN¥121.91 Million | ▼ -55.3% |
| 2017 | 2.81x | CN¥224.68 Million | CN¥79.88 Million | CN¥144.68 Million | ▲ +321.2% |
| 2016 | 0.67x | CN¥311.62 Million | CN¥466.62 Million | CN¥159.34 Million | ▲ +22.7% |
| 2015 | 0.54x | CN¥224.99 Million | CN¥413.23 Million | CN¥121.04 Million | ▲ +123.4% |
| 2014 | 0.24x | CN¥96.49 Million | CN¥395.83 Million | CN¥96.49 Million | ▼ -61.1% |
| 2013 | 0.63x | CN¥88.74 Million | CN¥141.76 Million | CN¥88.74 Million | ▼ -93.2% |
| 2012 | 9.23x | CN¥180.16 Million | CN¥19.52 Million | CN¥180.16 Million | ▲ +865.3% |
| 2011 | 0.96x | CN¥193.07 Million | CN¥201.90 Million | CN¥193.07 Million | ▲ +446.8% |
| 2009 | 0.17x | CN¥21.91 Million | CN¥125.31 Million | CN¥21.91 Million | — |